Patent ID: 11964005
Assignee: RECEPTOS, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 0:
1. A method of treating atopic dermatitis comprising administering to a subject in need thereof a therapeutically effective amount of an anti-IL-13 antibody, or antigen binding fragment thereof, thereby treating atopic dermatitis in the subject, wherein the anti-IL-13 antibody comprises an antigen binding domain comprising six CDRs: CDR-H1, CDR-H2, CDR-H3, CDR-L1, CDR-L2, and CDR-L3, wherein:
(a) CDR-H1 comprises residues 31-37 of SEQ ID NO:2;
(b) CDR-H2 comprises residues 52-67 of SEQ ID NO:2;
(c) CDR-H3 comprises residues 100-112 of SEQ ID NO:2;
(d) CDR-L1 comprises residues 24-34 of SEQ ID NO:3;
(e) CDR-L2 comprises residues 50-56 of SEQ ID NO:3; and
(f) CDR-L3 comprises residues 89-97 of SEQ ID NO:3.